Delivery Order SPE2DE24D0013-SPE2D626F31GN
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $40.8K delivery order to Cepheid Inc. on January 27, 2026, for molecular diagnostic reagents and test kits under the XPRS4PLEX-10 contract vehicle. This delivery order, which is a child contract with a firm fixed-price structure and no set-aside designation, is scheduled for completion by February 3, 2026, and will be performed at Cepheid's headquarters in Sunnyvale, California. The award represents continued procurement of diagnostic...
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California, a delivery order valued at $3,400 under contract XPRS4PLEX-10 on January 9, 2026. This firm fixed-price delivery order, with an ultimate completion date of January 16, 2026, is a child contract issued without set-aside designation and represents procurement of diagnostic testing supplies for federal healthcare operations. The award falls...
- The Department of Defense Medical Supply Chain (Defense Logistics Agency) awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $27,863.40 on January 8, 2026. This delivery order, issued under the contract number 4570456612 (XPRS4PLEX-10), is a child award under a larger indefinite delivery vehicle and calls for diagnostic reagents and test kits for the GeneXpert diagnostic platform. The contract carries no set-aside...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $20.4K to Cepheid Inc. on January 13, 2026, for diagnostic testing supplies and reagents. This delivery order, designated XPRS4PLEX-10, is a child contract under a larger Indefinite Delivery Vehicle and carries a firm fixed-price structure with no set-aside designation. The order is scheduled for completion by January 21, 2026, and will be performed at Cepheid's headquarters location in Sunnyvale, California....
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $14,745.20 firm fixed-price delivery order (XPRSMVP-10) by the Defense Logistics Agency Medical Supply Chain on January 16, 2026, with an ultimate completion date of January 26, 2026. This delivery order, which carries no set-aside designation, represents a child contract under a larger indefinite delivery vehicle and procures diagnostic testing supplies, reagents, or test kits...
- The Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $3,194.60 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems and reagents. The delivery order (Contract No. 4570644785 ! GXCT/NG-10) was issued on January 26, 2026, with an ultimate completion date of February 2, 2026, and represents a child contract under a larger indefinite delivery vehicle. This order procures diagnostic testing supplies, test kits,...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $26,627.40 delivery order (XPRSMVP-10) to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with a completion date of September 26, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a continuation of the agency's procurement of diagnostic testing solutions from Cepheid, a company specializing in advanced molecular diagnostic systems and...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,720 on October 29, 2025, by the Defense Logistics Agency Medical Supply Chain for diagnostic testing supplies and reagents. The delivery order, designated as XPRS4PLEX-10, is structured as a firm fixed-price contract with an ultimate completion date of November 5, 2025, and no set-aside designation. This award falls under Cepheid's broader contracting...
- The U.S. Defense Department's Medical Supply Chain organization awarded Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, a $4,108.25 firm fixed-price delivery order (Contract No. 4569031063) on August 7, 2025, with completion scheduled for August 14, 2025. This delivery order carries no set-aside designation and represents a procurement of diagnostic solutions from Cepheid's established product portfolio. The award leverages Cepheid's expertise in molecular...
- The Defense Logistics Agency Medical Supply Chain awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. on December 8, 2025, with an ultimate completion date of December 15, 2025. This delivery order, designated XPRS4PLEX-10, represents a small procurement of diagnostic reagents and test kits for Cepheid's GeneXpert diagnostic platform. The contract carries no set-aside designation and is being performed at Cepheid's headquarters location in Sunnyvale, California. As a leading federal...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F31GNDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $19,645.20 delivery order to Cepheid Inc. on January 28, 2026, for molecular diagnostic testing supplies and reagents under a firm fixed-price contract type with an ultimate completion date of February 4, 2026. This delivery order, identified as XPRS4PLEX-10, represents a child contract with no set-aside designation and will be performed at Cepheid's headquarters in Sunnyvale, California. The award leverages Cepheid's established federal contracting relationship and technical expertise as a primary supplier of advanced molecular diagnostic systems, particularly its GeneXpert diagnostic platform and associated testing capabilities for infectious diseases. This delivery order is part of Cepheid's broader federal procurement portfolio with the Department of Veterans Affairs, which includes two significant Indefinite Delivery Contracts valued at $6.7 million and $32.8 million respectively, extending through 2029 and 2030. Cepheid serves as a core supplier of diagnostic reagents, test kits, and molecular testing solutions across multiple federal healthcare agencies including the Defense Health Agency, Indian Health Service, and U.S. Coast Guard. The company's specialized capabilities in rapid molecular diagnostics for conditions such as COVID-19, influenza, respiratory syncytial virus, tuberculosis, and antimicrobial-resistant pathogens position it as a critical component of the federal government's clinical laboratory infrastructure and infectious disease detection capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.6k | 1/27/26 |